NCT07636876

The Italian Multiple Sclerosis and Related Disorders Register

ENROLLING_BY_INVITATIONOBSERVATIONAL

Trial Details

Start: 2014-09-17Est. Completion: 2026-07

Enrollment target: 96,000 participants

Locations

Muscular Atrophy, Spinal

In this study, researchers will learn more about the effects and safety of BIIB115, also known as salanersen. Specifica…

Chicago, United StatesEst. completion Nov 28, 2028

Relapsing Multiple Sclerosis

This open label, single arm study will evaluate the PK and PD effects of fenebrutinib in children and adolescents with R…

Rosario, ArgentinaEst. completion Jun 8, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.